It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Metabolite-level regulation of enzyme activity is important for microbes to cope with environmental shifts. Knowledge of such regulations can also guide strain engineering for biotechnology. Here we apply limited proteolysis-small molecule mapping (LiP-SMap) to identify and compare metabolite-protein interactions in the proteomes of two cyanobacteria and two lithoautotrophic bacteria that fix CO2 using the Calvin cycle. Clustering analysis of the hundreds of detected interactions shows that some metabolites interact in a species-specific manner. We estimate that approximately 35% of interacting metabolites affect enzyme activity in vitro, and the effect is often minor. Using LiP-SMap data as a guide, we find that the Calvin cycle intermediate glyceraldehyde-3-phosphate enhances activity of fructose-1,6/sedoheptulose-1,7-bisphosphatase (F/SBPase) from Synechocystis sp. PCC 6803 and Cupriavidus necator in reducing conditions, suggesting a convergent feed-forward activation of the cycle. In oxidizing conditions, glyceraldehyde-3-phosphate inhibits Synechocystis F/SBPase by promoting enzyme aggregation. In contrast, the glycolytic intermediate glucose-6-phosphate activates F/SBPase from Cupriavidus necator but not F/SBPase from Synechocystis. Thus, metabolite-level regulation of the Calvin cycle is more prevalent than previously appreciated.
A proteolysis-coupled mass spectrometry analysis is used to examine metabolite-protein interaction in cyanobacteria and finds that the regulation exerted by metabolites on the Calvin cycle is more numerous than previously thought.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details



1 KTH - Royal Institute of Technology, Department of Protein Science, Science for Life Laboratory, Stockholm, Sweden (GRID:grid.5037.1) (ISNI:0000000121581746)
2 KTH - Royal Institute of Technology, Department of Fiber and Polymer Technology, Science for Life Laboratory, Stockholm, Sweden (GRID:grid.5037.1) (ISNI:0000000121581746)
3 KTH - Royal Institute of Technology, Department of Protein Science, Science for Life Laboratory, Stockholm, Sweden (GRID:grid.5037.1) (ISNI:0000000121581746); SINTEF Industry, Department of Biotechnology and Nanomedicine, Trondheim, Norway (GRID:grid.5037.1)
4 Max Delbrück Center for Molecular Medicine in the Helmholtz Association, Berlin, Germany (GRID:grid.419491.0) (ISNI:0000 0001 1014 0849)